32 stories found
Reality TV personality Teddi Mellencamp revealed she asked her doctor for GLP-1 medications to address weight gain experienced during her cancer treatment. She openly discussed her decision to seek these drugs for weight management.
A new report examines how various elements, including GLP-1 medications, male physiological factors, and lifestyle choices, contribute to and affect fertility issues.
Transformative wonder drugs or overhyped sticking plasters on a much deeper problem?
Several US states are discontinuing Medicaid coverage for GLP-1 weight-loss drugs due to rising demand and costs. This decision comes as dietitians offer advice on how to maintain adequate nutrition while using these medications.
A columnist discusses her conflicted feelings as body-positivity influencers she follows begin taking GLP-1 drugs, expressing a desire for them to remain 'chubby'.
Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in patients with Type 2 diabetes.
Companies producing sauces and spices are seeing increased deal interest, as the rise of GLP-1 weight-loss drugs is reportedly leading Americans to seek out more flavorful, 'hot stuff'.
Increasingly popular GLP-1 drugs used to treat diabetes and obesity show promise in fighting multiple substance use disorders
My day at Delmonico's included potatoes in various forms: raw, mashed, and fried. Alice Tecotzky I spent a day at Delmonico's, a classic Wall Street steakhouse, as the team got ready for lunch. I saw how RTO and the latest iteration of office perks have transformed Wall Street's lunch culture. Though GLP-1s have swept the finance world, Delmonico's hasn't seen much of an impact. A few weeks ago, I, someone who generally abstains from beef but is committed to understanding the modern power l...
FDA chief Marty Makary addresses the contentious period for the agency, marked by significant staff and budget cuts, and discusses changes to vaccine policy and the use of compounded GLP-1s.
US farmers are increasingly planting peas and lentils, adapting to growing consumer demand for protein-rich foods and the influence of GLP-1 weight-loss drugs on dietary habits.
Eli Lilly's CEO has voiced disappointment that only a small fraction of Americans are currently using GLP-1 medications, a class of drugs used for conditions like diabetes and weight loss. The statement highlights concerns about the accessibility or uptake of these treatments.
New evidence suggests that GLP-1 medications provide health benefits to individuals even if they do not experience significant weight loss, expanding the understanding of their therapeutic effects.
The family behind Tapito, an iconic LA hot sauce, decided to sell their business due to a surge in demand for hot sauce and other condiments, attributed to the growing use of weight-loss drugs like GLP-1s.
Beyond their success as weight loss medications, GLP-1 drugs are now being investigated for their potential to help mitigate the opioid crisis, which claims over 100,000 lives annually from overdoses.
New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound after stopping GLP-1 medications.
A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.
US study suggests GLP-1s, used to treat type 2 diabetes, could also reduce risk of people already using substances from overdosing Weight loss drugs could help people avoid getting addicted to…
The manufacturing process for GLP-1 medications, a class of drugs used for weight loss and diabetes, is being scrutinized for its significant environmental impact.
Health insurers are raising questions about a new Medicare program that will offer GLP-1 medications to seniors for $50 per month, leading to a drop in shares for pharmaceutical companies like Novo Nordisk and Eli Lilly amid concerns over coverage plans.
A recent comprehensive review has concluded that new Alzheimer's drugs, particularly those targeting amyloid, offer little meaningful benefit to patients and may present more risks than advantages. This finding challenges the efficacy of much-hyped treatments for the neurodegenerative disease.
New evidence suggests that GLP-1 medications, while primarily known for weight loss, are providing health benefits to users even if they don't experience significant weight reduction. This indicates a broader therapeutic potential for these drugs.
Equity research firm Bernstein estimates that apparel retailers could see an annual boost of up to $13 billion in spending as millions of people using GLP-1 drugs refresh their wardrobes due to weight loss.
Scientists have identified concerning effects that occur when individuals cease taking GLP-1 medications.
BMI is just B.S. It doesn’t accurately define what it means to be overweight.
Eli Lilly has implemented artificial intelligence to significantly increase the production of its popular GLP-1 class of drugs.
Savannah Chrisley's prescription weight loss website is under a federal microscope ... 'cause the FDA warned her about making false and misleading claims about GLP-1s.
GLP-1 drugs for weight loss are growing in popularity in the U.S. and across the world. Here's what some users say about their experiences with the medicines.